Stay updated on KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedA new revision entry labeled v3.5.5 was added to the study record history, updating the history from the previous v3.5.4 revision.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision label in the page footer updated from v3.5.3 to v3.5.4, indicating a new version of the record history for this study. The change represents an internal update to the page's revision metadata rather than a modification to study details.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision entry (v3.5.3) was added to the Record History, replacing the previous revision (v3.5.2) to reflect an updated version of the study record.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision v3.5.2 was added to the study history and revision v3.5.0 was removed.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded a new revision entry v3.5.0 and deleted the previous revision v3.4.3 in the study record history.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the study record history.SummaryDifference0.1%

Stay in the know with updates to KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.